Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,059 | 7,942 | 8,016 | 0 | N/A |
| TOTAL | $54,401 | $8,030 | $8,271 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 486 | 759 | 1,197 | 0 | N/A |
| Other Non-Current Assets | 113 | 2,448 | 35 | 0 | 0 |
| TOTAL | $599 | $3,207 | $1,232 | $N/A | $N/A |
| Total Assets | $55,000 | $11,237 | $9,503 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 94 | 0 | N/A |
| Accounts payable and accrued liabilities | 2,458 | 1,746 | 1,107 | 0 | 0 |
| Accrued Expenses | 1,987 | 850 | 482 | 0 | N/A |
| TOTAL | $5,202 | $5,353 | $1,825 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,749 | 2,876 | 1,769 | 0 | N/A |
| Deferred Revenues | 506 | 1,115 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 3,223 | 307 | 170 | 0 | 0 |
| TOTAL | $12,972 | $3,538 | $1,939 | $N/A | $N/A |
| Total Liabilities | $18,174 | $8,891 | $3,764 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 905 | 812 | N/A | N/A | N/A |
| Common Shares | 18 | 2 | 1 | 0 | N/A |
| Retained earnings | -91,750 | -57,594 | -39,569 | 0 | N/A |
| Other shareholders' equity | 0 | 56,678 | 45,035 | 0 | 0 |
| TOTAL | $36,826 | $2,346 | $5,739 | $0 | $N/A |
| Total Liabilities And Equity | $55,000 | $11,237 | $9,503 | $0 | $0 |